Obregon, Mark Vincent T.

HRN: 29-29-36  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/21/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
07/21/2026
07/27/2026
IV
4.5g
Q8h
CAP-HR
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: